A specialty-based community offering cardiologic CME/CE courses, resources, and news, centered on you.
Cardiology Advisor Institute Spotlight Course
Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management
1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24
Additional Cardiology Courses
Optimizing Antiplatelet Therapy in Cardiogenic Shock
1.00 CME: Pharmacokinetic/pharmacodynamic profile of parenteral antiplatelet agents and future antiplatelet and antithrombotic therapeutic targets. Exp 5/30/23
Mechanical Circulatory Support: Right, Left, and Biventricular
1.00 CME: Right-Sided MCS with RA-PA Pump and Left-Sided MCS with LA-AO Pump. Emerging role of VA ECMO in cath lab and biventricular MCS. Exp 5/30/23
Evolution of Lipid Management: New Approaches to Addressing Clinical Challenges
1.50 CME: This course provides vital information on the treatment of dyslipidemia and lipid management. Exp 8/22/23
TAVR Update: Underutilization, Clinical Outcomes, Costs, and Future Directions
1.00 CME CE: Many patients who would benefit from transcatheter aortic valve replacement go untreated. Learn about cost-saving TAVR implementation. Exp 9/30/2023
Homozygous Familial Hypercholesterolemia: Improving Outcomes Through Timely Diagnosis and Treatment
1.00 CME CE: Homozygous Familial Hypercholesterolemia is rare, but clinicians in cardiology, primary care, and pediatrics can improve outcomes. Exp 10/31/23
Are You Ready? DOACs for Pediatric Patients with Venous Thromboembolism
0.50 CME: Pediatric cardiology expert, Riten Kumar, MD, MSc, leads this digital newsletter on the latest data on pediatric VTE and the role of DOACs. Exp 4/29/23
Better Weight Management, Better Outcomes: Practical Approaches to Managing the Interrelated Conditions of Obesity and PCOS
2.00 CME CE: This program is for clinicians interested in the treatment of PCOS and other women’s health challenges related to excess weight or obesity. 6/27/23
Scleroderma-Associated Pulmonary Arterial Hypertension: Early Detection = Better Outcomes
0.75 CME CNE: Interact with virtual patients as you manage scleroderma-associated pulmonary arterial hypertension with expert clinical mentoring. Exp. 9/14/23
Digital Pathway – Changing the Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes
1.50 CME CE: Risk of a recurrent CV event post-MI is substantial. Targeted LDL-C optimization of lipid lowering therapy remains suboptimal. Exp 9/23/23
Digital Pathway – The Evolving Landscape of LDL-C Reduction in High-Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk
1.00 CME CE: Experts discuss the efficacy and safety of new approaches of LDL-C lowering therapy and current treatment options’ application to patient care. Exp 11/4/23
Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs
1.00 CME: Learn about the etiology of anemia in CKD, the effects on CV disease, and advantages and limitations of current management strategies. Exp 11/16/23
Mineralocorticoid Receptor Antagonists: Addressing Residual Risk in Patients with Cardiac Disease, T2DM, and CKD
1.00 CME: Provides cardiologists information about the interrelationship of CVD and renal disease and the efficacy and safety of MRAs as well as expert guidance about the role of MRAs in the management of patients with T2DM, CKD, and CVD. Exp 12/20/23
